Alan Herbert Email & Phone Number
@insideoutbio.com
4 phones found area 856 and 617
LinkedIn matched
Who is Alan Herbert? Overview
A concise factual answer block for searchers comparing this professional profile.
Alan Herbert is listed as Therapeutics for Turning Cold Tumors Hot. Designs powered by Human Genetics! at InsideOutBio, based in Suffolk County, Massachusetts, United States. AeroLeads shows a work email signal at insideoutbio.com, phone signal with area code 856, 617, and a matched LinkedIn profile for Alan Herbert.
Alan Herbert previously worked as Founder at Insideoutbio and Founder at Insideoutbio. Alan Herbert holds Doctor Of Philosophy (Phd), Immunobiology from The University Of Auckland.
Email format at InsideOutBio
This section adds company-level context without repeating Alan Herbert's masked contact details.
AeroLeads found 1 current-domain work email signal for Alan Herbert. Compare company email patterns before reaching out.
About Alan Herbert
Discoveries in Z-DNA Biology, RNA Editing and the Encoding of Genetic Information by Flipons. Advances in Immunology based on Contextual Cell Death and the Regulation of Anti-Tumor Responses by Complement-mediated control of Immune Synapse Formation.At InsideOutBio, my focus as founder and head of discovery is on translating the power of human genetics to therapeutics. We have developed a novel therapeutic for the induction of anti-tumor responses. Our approach exploits the genetics of the complement system. and pioneers the targeting of the Complement C3 Checkpoint. We have been able to quickly move from concept to proof of mechanism and produce tumor regression in our preclinical models. All of this was done at low cost with the goal of moving safely to the clinic as fast as we can. InsideOutBio has also contributed to our understanding of the role of RNA editing in cancer. Data gathered by many investigators examining families with certain Mendelian diseases provided evidence for a role of the left-handed Z-DNA conformation in regulating interferon responses essential to anti-tumor immunity. The work supports the targeting of Z-DNA binding proteins and RNA editing as a new therapeutic approach to treating cancer. While cancer biology traditionally focuses on mutations to codons, our interest is on the role of flipons in tumor biology. Flipons consist of sequences that encode alternative DNA conformations like Z-DNA. They allow the compilation of different RNA transcripts from the same DNA sequence. Besides cancer, they play a role in many other diseases.
Listed skills include Drug Discovery, Genetics And Genomics, Bioinformatics, Human Immunology, and 35 others.
Alan Herbert's current company
Company context helps verify the profile and gives searchers a useful next step.
Alan Herbert work experience
A career timeline built from the work history available for this profile.
Founder
A Stealth Immuno-Oncology Company Developing a Novel Platform for Engineered Therapeutics. The IP is wholly owned by InsideOutBio.
Associate Principal Scientist Human Genetics And Pharmacogenetics
While at Merck Research Laboratories, I developed a novel Bioinformatic Algorithm to analyze the Moffat Cancer Center Collection of 10,000 Tumor-Derived MicroArrays that lead to the initiation of a novel Checkpoint Inhibitor Program. Another company, Calithera, recently published validation of the target IL4I1 in synergy with a checkpoint inhibitor using a pre-clinical melanoma model. Other work in target identification and validation in immunology and immuno-oncology was also performed at Merck in support of other programs that are still ongoing.1. St Pierre C, Guo J, Shin JD, Engstrom LW, Lee HH, Herbert A, Surdi L, Baker J, Salmon M, Shah S, Ellis JM, Houshyar H, Crackower MA, Kleinschek MA, Jones DC, Hicks A, Zaller DM, Alves SE, Ramadas RA. A human tissue-based functional assay platform to evaluate the immune function impact of small molecule inhibitors that target the immune system. PLoS One. 2017;12(7):e0180870. Epub 2017/07/19. doi: 10.1371/journal.pone.0180870. PubMed PMID: 28719615; PMCID: PMC5515432.
Associate Professor
The work I initiated at Boston University was the first Genome Wide Association Study (GWAS) in a human population based on data collected by the Framingham Heart Study. New methods based on the family structure provided a solution to the multiple testing problem arising from the use of hundreds of polymorphic markers in this approach. This work provided initial validation of the GWAS approach.1. Herbert A. The fat tail of obesity as told by the genome. Curr Opin Clin Nutr Metab Care. 2008;11(4):366-70. Epub 2008/06/11. doi: 10.1097/MCO.0b013e3283034990. PubMed PMID: 18541993; PMCID: PMC2770374.2. Herbert A, Lenburg ME, Ulrich D, Gerry NP, Schlauch K, Christman MF. Open-access database of candidate associations from a genome-wide SNP scan of the Framingham Heart Study. Nat Genet. 2007;39(2):135-6. Epub 2007/01/31. doi: 10.1038/ng0207-135. PubMed PMID: 17262019.3. Herbert A, Gerry NP, McQueen MB, Heid IM, Pfeufer A, Illig T, Wichmann HE, Meitinger T, Hunter D, Hu FB, Colditz G, Hinney A, Hebebrand J, Koberwitz K, Zhu X, Cooper R, Ardlie K, Lyon H, Hirschhorn JN, Laird NM, Lenburg ME, Lange C, Christman MF. A common genetic variant is associated with adult and childhood obesity. Science. 2006;312(5771):279-83. Epub 2006/04/15. doi: 10.1126/science.1124779. PubMed PMID: 16614226.
Consultant
Coriell Personalized Medicine CollaborativePersonalized medicine> Provided consultative guidance and advice to the Coriell Personalized Medicine Collaborative and Operation Smile in the areas of personalized medicine; drafted IRB protocols for the successful launch of the study.> Provided consultative guidance to Operation Smile to establish protocols for the Operation Smile International Family Study to understand the causes of Cleft Lip and Palate, adapting high tech approaches to the low tech environment found in many of the countries Operation Smile operates in.
Research Scientist
My work on Z-DNA lead to the identification of the RNA editing enzyme as the first high affinity binding protein for the left-handed conformation. Mapping of mutations to the Z-DNA binding domain to diseases using Mendelian Genetics established a role for Z-DNA in biology and support for the flipon concept describing the encoding of genetic information in DNA structure rather than just sequence. The role of ADAR based on the Z-DNA dependent regulation of type I interferon responses has opened up a new paradigm for cancer treatment, orthogonal to those based on codon mutations. This work has advanced our basic understanding of the different ways DNA encodes genetic information and to the clinical application of this new biology.1. Herbert A. Mendelian disease caused by variants affecting recognition of Z-DNA and Z-RNA by the Zalpha domain of the double-stranded RNA editing enzyme ADAR. Eur J Hum Genet. 2020;28(1):114-7. Epub 2019/07/20. doi: 10.1038/s41431-019-0458-6. PubMed PMID: 31320745; PMCID: PMC6906422.2. Herbert A. Z-DNA and Z-RNA in human disease. Commun Biol. 2019;2:7. Epub 2019/02/08. doi: 10.1038/s42003-018-0237-x. PubMed PMID: 30729177; PMCID: PMC6323056.3. Herbert A. ADAR and Immune Silencing in Cancer. Trends Cancer. 2019;5(5):272-82. Epub 2019/06/09. doi: 10.1016/j.trecan.2019.03.004. PubMed PMID: 31174840.4. Herbert A. A Genetic Instruction Code Based on DNA Conformation. Trends Genet. 2019;35(12):887-90. 5. Herbert A, Rich A. The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1. Proc Natl Acad Sci U S A. 2001;98(21):12132-7.6. Herbert A, Alfken J, Kim YG, Mian IS, Nishikura K, Rich A. A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase. Proc Natl Acad Sci U S A. 1997;94(16):8421-67. Herbert AG, Rich A. A method to identify and characterize Z-DNA binding proteins using a linear oligodeoxynucleotide. Nucleic Acids Res. 1993;21(11):2669-72
Alan Herbert education
Doctor Of Philosophy (Phd), Immunobiology
Bachelor Of Medicine, Bachelor Of Surgery (Mb.Chb) (Md Equivalent)
Frequently asked questions about Alan Herbert
Quick answers generated from the profile data available on this page.
What company does Alan Herbert work for?
Alan Herbert works for InsideOutBio.
What is Alan Herbert's role at InsideOutBio?
Alan Herbert is listed as Therapeutics for Turning Cold Tumors Hot. Designs powered by Human Genetics! at InsideOutBio.
What is Alan Herbert's email address?
AeroLeads has found 1 work email signal at @insideoutbio.com for Alan Herbert at InsideOutBio.
What is Alan Herbert's phone number?
AeroLeads has found 4 phone signal(s) with area code 856, 617 for Alan Herbert at InsideOutBio.
Where is Alan Herbert based?
Alan Herbert is based in Suffolk County, Massachusetts, United States while working with InsideOutBio.
What companies has Alan Herbert worked for?
Alan Herbert has worked for Insideoutbio, Merck, Boston University, Coriell Institute For Medical Research, and Mit.
How can I contact Alan Herbert?
You can use AeroLeads to view verified contact signals for Alan Herbert at InsideOutBio, including work email, phone, and LinkedIn data when available.
What schools did Alan Herbert attend?
Alan Herbert holds Doctor Of Philosophy (Phd), Immunobiology from The University Of Auckland.
What skills is Alan Herbert known for?
Alan Herbert is listed with skills including Drug Discovery, Genetics And Genomics, Bioinformatics, Human Immunology, Tumor Immunology, Population Genetics, Statistical Genetics, and Protein Chemistry.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial